Annexon (ANNX) Accounts Payables (2019 - 2026)
Annexon's (ANNX) quarterly Accounts Payables came in at $17.5 million in Q1 2026, up 67.95% year-on-year from $10.4 million in Q1 2025, and up 17.4% quarter-over-quarter from $14.9 million in Q4 2025.
Annexon (ANNX) Accounts Payables (2019 - 2026) Analysis & Trends
Annexon's Accounts Payables history runs 8 years deep, the most recent figure standing at $17.5 million for Q1 2026.
- On a quarterly basis, Accounts Payables rose 67.95% year-over-year to $17.5 million in Q1 2026; TTM through Mar 2026 was $17.5 million, a 67.95% increase from a year earlier, with the FY2025 full-year figure at $14.9 million, up 43.21% from the prior year.
- Accounts Payables improved to $17.5 million in Q1 2026 per ANNX's latest filing, from $14.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $18.2 million in Q3 2025 and bottomed at $4.0 million in Q1 2024.
- The 5-year median for Accounts Payables is $9.4 million (2022), against an average of $9.4 million.
- Across the five-year window, Accounts Payables slumped 61.61% in 2024 and surged 179.08% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $7.4 million in 2022, then decreased by 26.01% to $5.5 million in 2023, then surged by 90.01% to $10.4 million in 2024, then soared by 43.21% to $14.9 million in 2025, then grew by 17.4% to $17.5 million in 2026.
- Per Business Quant, the three latest ANNX Accounts Payables figures stand at $17.5 million (Q1 2026), $14.9 million (Q4 2025), and $18.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | 17.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.53 Mn |
| Dec 31, 2025 | 14.93 Mn |
| Sep 30, 2025 | 18.22 Mn |
| Jun 30, 2025 | 11.52 Mn |
| Mar 31, 2025 | 10.44 Mn |
| Dec 31, 2024 | 10.43 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 3.97 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Sep 30, 2023 | 4.81 Mn |
| Jun 30, 2023 | 7.16 Mn |
| Mar 31, 2023 | 10.35 Mn |
| Dec 31, 2022 | 7.42 Mn |
| Sep 30, 2022 | 6.92 Mn |
| Jun 30, 2022 | 10.30 Mn |
| Mar 31, 2022 | 9.38 Mn |
| Dec 31, 2021 | 11.15 Mn |
| Sep 30, 2021 | 4.80 Mn |
| Jun 30, 2021 | 4.18 Mn |